Drug Shortage Report for MORPHINE SULFATE INJECTION USP

Last updated on 2020-02-27 History
Report ID 77018
Drug Identification Number 00649619
Brand name MORPHINE SULFATE INJECTION USP
Common or Proper name MORPHINE SULFATE INJECTION USP
Company Name ICU MEDICAL CANADA INC
Market Status MARKETED
Active Ingredient(s) MORPHINE SULFATE
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10
ATC code N02AA
ATC description OPIOIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-03-01
Actual start date 2019-03-01
Estimated end date 2020-04-01
Actual end date 2019-10-14
Shortage status Resolved
Updated date 2020-02-27
Company comments Product has been discontinued. DIN 00649619 was cancelled 2019-10-14
Health Canada comments
Contact Address 2600 BOUL ALFRED-NOBEL, SUITE 100
SAINT LAURENT, QUEBEC
CANADA H4S 0A9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2020-02-27 French Compare
v9 2020-02-27 English Compare
v8 2019-10-31 French Compare
v7 2019-10-31 English Compare
v6 2019-10-31 English Compare
v5 2019-08-20 French Compare
v4 2019-08-20 English Compare
v3 2019-03-02 English Compare
v2 2019-02-27 French Compare
v1 2019-02-27 English Compare